SCHEMBL13545865

SCHEMBL13545865

O=C(NCc1ccccc1Cl)c1[nH]nc2c1CCCC2

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 4/20 0.49
▸ POLB P06746 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ PKM P14618 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ P2RX7 Q99572 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13545861 0.87 HPGD (0.50) TP53POLBMAPTALDH1A1LMNA
SCHEMBL13545872 0.82 MAPK1 (0.45) TP53POLBMAPTNPC1ALDH1A1
SCHEMBL13545837 0.75 ROCK2 (0.46) POLBNPC1RAB9AALDH1A1LMNA
SCHEMBL13545773 0.75 KMT2A (0.72) TP53MAPTNPC1RAB9AALDH1A1
SCHEMBL950894 0.70 NPC1 (0.68) MAPTNPC1RAB9AALDH1A1MAPK1
SCHEMBL13545859 0.70 KMT2A (0.57) TP53POLBMAPTNPC1RAB9A
SCHEMBL17927741 0.69 HCAR2 (0.39) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL13545871 0.68 ALDH1A1 (0.56) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL14938844 0.68 POLB (0.54) TP53POLBMAPTNPC1RAB9A
SCHEMBL23657866 0.68 RAB9A (0.54) POLBMAPTNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 — — US disclosed
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 — — US disclosed
WO-2008080455-A1 TETRAHYDROBENZOISOXAZOLE - AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2008-07-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN CCNB3, TUBB3, CCNB1 TP53 711/4885POLB 827/4885MAPT 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback